Kemira stock plunged 7.3% in trading today after the company issued a profit warning and scaled back its 2026 profitability outlook, pointing to elevated raw material and logistics expenses associated with the prolonged conflict in Iran. Investors reacted to the update and a soft first-quarter earnings report with sustained selling pressure, driving the share price to a new 52-week intraday low of E15.29.
The company now expects 2026 revenue of E2.6 billion to E3.0 billion and operative EBITDA of E400 million to E500 million. Earlier guidance statements cited in company disclosures also referenced a revenue range of E2,600 E3,000 million alongside an operative EBITDA range reported as E470 E570 million - figures that market commentators have read as evidence of significant uncertainty around the year ahead.
Detailed first-quarter metrics released on April 24 underline the challenges facing the business. Kemira posted EPS of E0.29 for Q1, missing the consensus estimate of roughly E0.32. Revenue declined 4% year-on-year to E677.3 million, while operative EBITDA fell 13% to E117.3 million. The operative EBITDA margin narrowed to 17.3% from 19.1% in the same period a year earlier.
CEO Antti Salminen characterized the quarter as being dominated by a "really weak global economy" together with escalating geopolitical tensions, which he said produced strong headwinds across Kemira's operations. The Packaging & Hygiene Solutions segment was singled out as particularly pressured, with its operative EBITDA margin compressing to 10.1% from 12.0% year-on-year.
Analysts reacted by trimming expectations. Danske Bank issued a downgrade, and the consensus price target for the stock fell from E22.65 to E21.80, reflecting more cautious assumptions on revenue growth and margin prospects going forward.
Market context offered little offset to the company-specific news. Broad equity indices were trading lower as well, with the NASDAQ and the S&P 500 both in negative territory during the session, reinforcing a risk-off environment that has disproportionately affected mid-cap industrial and specialty chemicals names.
The combination of a meaningful earnings miss, shrinking segment profitability, analyst downgrades, heightened input costs - notably oil derivatives that represent roughly one-third of Kemira's cost base - and foreign exchange pressure has created a compounding negative dynamic for the stock. That dynamic pushed shares to levels not seen in over a year and raised doubts among investors about the likelihood of returning to an operative EBITDA margin in the company's quarterly target range of 18-21% in the near term.
For now, persistent selling and the now-lower profitability outlook are the primary drivers behind the move in Kemira's shares. The company flagged that raw material cost increases and ongoing FX headwinds could continue to pressure margins, contributing to the cautious tone from both management and market participants.
Key takeaways:
- Kemira issued a profit warning and lowered its operative EBITDA outlook for 2026, citing higher raw material and logistics costs tied to the prolonged conflict in Iran.
- Q1 results missed consensus on EPS and showed declines in revenue and operative EBITDA, with margins contracting year-on-year.
- Analyst downgrades and a weaker broader market reinforced the sell-off, pushing the stock to a 52-week intraday low.
Investors and market observers will be watching whether Kemira can stabilize margins and re-establish progress toward its quarterly operative EBITDA target range of 18-21%, amid elevated input-cost pressure and a cautious macro backdrop.